California, United States of America
Genentech is inviting applications for an exciting leadership role in a newly established T-cell Engineering and Development Department within Pharmaceutical Technical Development, US Biologics. Genentech is committed to develop personalized and T-cell-directed therapies to treat patients with cancer. As one building block of this commitment, Genentech is collaborating with Adaptive Biotechnologies, a leader in immune-sequencing, identification, and selection of personalized T-cell receptors against shared and private neo-antigens.
The successful candidate will have the opportunity and responsibility to establish an end-to-end CMC capability for an engineered T-cell Therapy. This includes but not limited to T-cell isolation and engineering, process development, automation, manufacturing, product control, and T-cell characterization (in collaboration with our Cancer Immunology research group). New and innovative approaches will be welcome.
The successful candidate will:
A member of the Roche Group, Genentech has been at the forefront of the biotechnology industry for more than 40 years, using human genetic information to develop novel medicines for serious and life-threatening diseases. Genentech has multiple therapies on the market for cancer & other serious illnesses. Please take this opportunity to learn about Genentech where we believe that our employees are our most important asset & are dedicated to remaining a great place to work.
The next step is yours. To apply today, click on the "Apply online" button.
Genentech is an equal opportunity employer & prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital & veteran status. For more information about equal employment opportunity, visit our Genentech Careers page.
These are our stories - stories of the obstacles and opportunities that define and celebrate the unique people at Genentech